Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on January 30, 2025, to announce its financial results for the fiscal quarter and full year ended December 31, 2024. The press release containing these detailed results is furnished as an exhibit to this filing, providing investors with key performance metrics and financial condition updates for the period. This report serves as the primary disclosure vehicle for the company's latest financial performance, enabling stakeholders to assess the company's recent operational success and outlook.
Key Highlights
- 1Thermo Fisher Scientific (TMO) announced its financial results for the fourth quarter and full fiscal year ended December 31, 2024.
- 2The company furnished a press release on January 30, 2025, containing these results as Exhibit 99.1.
- 3This filing is an 8-K Current Report, indicating a material event for the company.
- 4Investors can find detailed financial performance and operational data within the furnished press release.
- 5The report includes information relevant to both the quarterly and annual financial standing of TMO.
- 6The filing is intended to inform investors and the market about the company's latest financial outcomes.
Frequently Asked Questions
The detailed financial results for the fiscal quarter and full year ended December 31, 2024, are provided in the press release furnished as Exhibit 99.1 to this Form 8-K, filed on January 30, 2025.
This is an 8-K Current Report filing. It signifies a material event for Thermo Fisher Scientific, specifically the announcement of its financial results for the period ended December 31, 2024.
The information contained in this report and its exhibits is furnished and shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section, unless expressly set forth by specific reference in another filing.